Prognostic usefulness of serial c-reactive protein measurements in st-elevation acute myocardial infarction

American Journal of Cardiology

Volumn 111, Issue 1, 2013, Pages 26-30

  Makrygiannis, Stamatis S ^a   Ampartzidou, Olga S ^a   Zairis, Michael N ^a   Patsourakos, Nikolaos G ^a   Pitsavos, Christos ^b   Tousoulis, Dimitris ^b   Prekates, Athanasios A ^a   Foussas, Stefanos G ^a   Cokkinos, Dennis V ^c  

^a TZANEIO GENERAL HOSPITAL OF PIRAEUS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c BIOMEDICAL RESEARCH FOUNDATION   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; C REACTIVE PROTEIN; CLOPIDOGREL; CREATINE KINASE MB; ENOXAPARIN; HEPARIN; RETEPLASE; STREPTOKINASE; TENECTEPLASE; TROPONIN I; TROPONIN T;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CREATINE KINASE BLOOD LEVEL; DRUG DOSE TITRATION; ENZYME BLOOD LEVEL; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HEART DEATH; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CAUSE OF DEATH; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; GREECE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84870996846     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.08.041     Document Type: Article

References (29)

1. G.K. Hansson Inflammation, atherosclerosis, and coronary artery disease N Engl J Med 352 2005 1685 1695
2. L.P. He, X.Y. Tang, W.H. Ling, W.Q. Chen, and Y.M. Chen Early C-reactive protein in the prediction of long-term outcomes after acute coronary syndromes: a meta-analysis of longitudinal studies Heart 96 2010 339 346
3. B.M. Scirica, D.A. Morrow, C.P. Cannon, J.A. de Lemos, S. Murphy, M.S. Sabatine, S.D. Wiviott, N. Rifai, C.H. McCabe, E. Braunwald Thrombolysis In Myocardial Infarction (TIMI) Study Group Clinical application of C-reactive protein across the spectrum of acute coronary syndromes Clin Chem 53 2007 1800 1807
4. N.D. Brunetti, R. Troccoli, M. Correale, P.L. Pellegrino, and M. Di Biase C-reactive protein in patients with acute coronary syndrome: correlation with diagnosis, myocardial damage, ejection fraction and angiographic findings Int J Cardiol 109 2006 248 256
5. P.L. Sánchez, M.V. Rodríguez, E. Villacorta, C. Albarrán, I. Cruz, J.M. Moreiras, F. Martín, P. Pabón, F. Fernández-Avilés, and C. Martín-Luengo Kinetics of C-reactive protein release in different forms of acute coronary syndrome [article in Spanish] Rev Esp Cardiol 59 2006 441 447
6. J.S. Zebrack, J.L. Anderson, C.A. Maycock, B.D. Horne, T.L. Bair, J.B. Muhlestein Intermountain Heart Collaborative (IHC) Study Group Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction Am J Cardiol 89 2002 145 149
7. C. Dedobbeleer, C. Melot, and M. Renard C-reactive protein increase in acute myocardial infarction Acta Cardiol 59 2004 291 296
8. A.K. Tsakiris, P.G. Marnelos, N.S. Nearchou, J.E. Papadakis, E.N. Karatzis, and P.D. Skoufas The influence of thrombolytic therapy on C-reactive protein in ST-segment elevation acute myocardial infarction Hellenic J Cardiol 47 2006 218 222
9. K. Pietila, A. Harmoinen, W. Hermens, M.L. Simoons, F. Van de Werf, and M. Verstraete Serum C-reactive protein and infarct size in myocardial infarct patients with a closed versus an open infarct-related coronary artery after thrombolytic therapy Eur Heart J 14 1993 915 919
10. S. De Servi, M. Mariani, G. Mariani, and A. Mazzone C-reactive protein increase in unstable coronary disease cause or effect? J Am Coll Cardiol 46 2005 1496 1502
11. A. Shah, G.S. Wagner, C.B. Granger, C.M. O'Connor, C.L. Green, K.M. Trollinger, R.M. Califf, and M.W. Krucoff Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis J Am Coll Cardiol 35 2000 666 672
12. M.W. Krucoff, M.A. Croll, J.E. Pope, C.B. Granger, C.M. O'Connor, K.N. Sigmon, B.L. Wagner, J.A. Ryan, K.L. Lee, and D.J. Kereiakes Continuous 12-lead ST-segment recovery analysis in the TAMI 7 study. Performance of a non-invasive method for real-time detection of failed myocardial reperfusion Circulation 88 1993 437 446
13. A. Langer, M.W. Krucoff, P. Klootwijk, R. Veldkamp, M.L. Simoons, C. Granger, R.M. Califf, and P.W. Armstrong Noninvasive assessment of speed and stability of infarct-related artery reperfusion: results of the GUSTO ST segment monitoring study J Am Coll Cardiol 25 1995 1552 1557
14. I. Kushner, M.L. Broder, and D. Karp Control of the acute phase response. Serum C-reactive protein kinetics after acute myocardial infarction J Clin Invest 61 1978 235 242
15. F.C. de Beer, C.R. Hind, K.M. Fox, R.M. Allan, A. Maseri, and M.B. Pepys Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction Br Heart J 47 1982 239 243
16. K.O. Pietilä, A.P. Harmoinen, J. Jokiniitty, and A.I. Pasternack Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment Eur Heart J 17 1996 1345 1349
17. T. Anzai, T. Yoshikawa, H. Shiraki, Y. Asakura, M. Akaishi, H. Mitamura, and S. Ogawa C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction Circulation 96 1997 778 784
18. A. Ziakas, S. Gavrilidis, G. Giannoglou, E. Souliou, K. Gemitzis, D. Kalampalika, M.A. Vayona, I. Pidonia, G. Parharidis, and G. Louridas In-hospital and long-term prognostic value of fibrinogen, CRP, and IL-6 levels in patients with acute myocardial infarction treated with thrombolysis Angiology 57 2006 283 293
19. O. Dimitrijević, B.D. Stojcevski, S. Ignjatović, and N.M. Singh Serial measurements of C-reactive protein after acute myocardial infarction in predicting one-year outcome Int Heart J 47 2006 833 842
20. M. Nikfardjam, M. Müllner, W. Schreiber, E. Oschatz, M. Exner, H. Domanovits, A.N. Laggner, and K. Huber The association between C-reactive protein on admission and mortality in patients with acute myocardial infarction J Intern Med 247 2000 341 345
21. M.N. Zairis, S.J. Manousakis, A.S. Stefanidis, O.A. Papadaki, G.K. Andrikopoulos, C.D. Olympios, J.J. Hadjissavas, S.K. Argyrakis, and S.G. Foussas C-reactive protein levels on admission are associated with response to thrombolysis and prognosis after ST-segment elevation acute myocardial infarction Am Heart J 144 2002 782 789
22. M.N. Zairis, E.N. Adamopoulou, S.J. Manousakis, A.G. Lyras, G.P. Bibis, O.S. Ampartzidou, C.S. Apostolatos, F.A. Anastassiadis, J.J. Hatzisavvas, S.K. Argyrakis, S.G. Foussas, and Biomarkers of Inflammation and Outcome in Acute Coronary Syndromes (BIAS) Investigators The impact of hs C-reactive protein and other inflammatory biomarkers on long-term cardiovascular mortality in patients with acute coronary syndromes Atherosclerosis 194 2007 397 402
23. P. Ortolani, A. Marzocchi, C. Marrozzini, T. Palmerini, F. Saia, N. Taglieri, F. Baldazzi, S. Silenzi, M.L. Bacchi-Reggiani, P. Guastaroba, R. Grilli, and A. Branzi Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention Eur Heart J 29 2008 1241 1249
24. J.J. Smit, J.P. Ottervanger, R.J. Slingerland, J.J. Kolkman, H. Suryapranata, J.C. Hoorntje, J.H. Dambrink, A.T. Gosselink, M.J. de Boer, F. Zijlstra, A.W. van 't Hof ON-TIME Study Group Comparison of usefulness of C-reactive protein versus white blood cell count to predict outcome after primary percutaneous coronary intervention for ST elevation myocardial infarction Am J Cardiol 101 2008 446 451
25. M.L. Canale, S. Stroppa, P. Caravelli, A.S. Petronio, R. Mariotti, M. Mariani, A. Balbarini, and A. Barsotti Admission C-reactive protein serum levels and survival in patients with acute myocardial infarction with persistent ST elevation Coron Artery Dis 17 2006 693 698
26. S. Tommasi, E. Carluccio, M. Bentivoglio, M. Buccolieri, M. Mariotti, M. Politano, and L. Corea C-reactive protein as a marker for cardiac ischemic events in the year after a first, uncomplicated myocardial infarction Am J Cardiol 83 1999 1595 1599
27. F. Bursi, S.A. Weston, J.M. Killian, S.E. Gabriel, S.J. Jacobsen, and V.L. Roger C-reactive protein and heart failure after myocardial infarction in the community Am J Med 120 2007 616 622
28. M.N. Akkus, G. Polat, M. Yurtdas, B. Akcay, N. Ercetin, D. Cicek, O. Doven, and N. Sucu Admission levels of C-reactive protein and plasminogen activator inhibitor-1 in patients with acute myocardial infarction with and without cardiogenic shock or heart failure on admission Int Heart J 50 2009 33 45
29. H. Kim, D.H. Yang, Y. Park, J. Han, H. Lee, H. Kang, H.S. Park, Y. Cho, S.C. Chae, J.E. Jun, and W.H. Park Incremental prognostic value of C-reactive protein and N-terminal proB-type natriuretic peptide in acute coronary syndrome Circ J 70 2006 1379 1384